ID   ALBU_HUMAN              Reviewed;         609 AA.
AC   P02768; E7ESS9; O95574; P04277; Q13140; Q645G4; Q68DN5; Q6UXK4;
AC   Q86YG0; Q8IUK7; Q9P157; Q9P1I7; Q9UHS3; Q9UJZ0;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1990, sequence version 2.
DT   10-MAY-2017, entry version 240.
DE   RecName: Full=Serum albumin;
DE   Flags: Precursor;
GN   Name=ALB;
GN   ORFNames=GIG20, GIG42, PRO0903, PRO1708, PRO2044, PRO2619, PRO2675,
GN   UNQ696/PRO1341;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT LYS-420.
RX   PubMed=6171778; DOI=10.1093/nar/9.22.6103;
RA   Lawn R.M., Adelman J., Bock S.C., Franke A.E., Houck C.M.,
RA   Najarian R.C., Seeburg P.H., Wion K.L.;
RT   "The sequence of human serum albumin cDNA and its expression in E.
RT   coli.";
RL   Nucleic Acids Res. 9:6103-6114(1981).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLY-121.
RX   PubMed=6275391; DOI=10.1073/pnas.79.1.71;
RA   Dugaiczyk A., Law S.W., Dennison O.E.;
RT   "Nucleotide sequence and the encoded amino acids of human serum
RT   albumin mRNA.";
RL   Proc. Natl. Acad. Sci. U.S.A. 79:71-75(1982).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3009475;
RA   Minghetti P.P., Ruffner D.E., Kuang W.J., Dennison O.E., Hawkins J.W.,
RA   Beattie W.G., Dugaiczyk A.;
RT   "Molecular structure of the human albumin gene is revealed by
RT   nucleotide sequence within q11-22 of chromosome 4.";
RL   J. Biol. Chem. 261:6747-6757(1986).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RA   Yang S., Zhang R.A., Qi Z.W., Yuan Z.Y.;
RT   "Human serum albumin.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT HIROSHIMA-1
RP   LYS-378.
RA   Huang M.C., Wu H.T.;
RT   "The cDNA sequences of human serum albumin.";
RL   Submitted (AUG-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Hinchliffe E.;
RT   "Induction of galactose regulated gene expression in yeast.";
RL   Patent number EP0248637, 09-DEC-1987.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RA   Yu Z., Fu Y.;
RT   "High expression HSA in Pichia for Pharmaceutical Use.";
RL   Submitted (AUG-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Wang F., Huang L.;
RT   "Cloning and sequence analysis of human albumin gene.";
RL   Submitted (SEP-2006) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RA   Kim J.W.;
RT   "Identification of a human cell growth inhibition gene.";
RL   Submitted (FEB-2004) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Fetal liver;
RX   PubMed=11483580; DOI=10.1101/gr.175501;
RA   Yu Y., Zhang C., Zhou G., Wu S., Qu X., Wei H., Xing G., Dong C.,
RA   Zhai Y., Wan J., Ouyang S., Li L., Zhang S., Zhou K., Zhang Y., Wu C.,
RA   He F.;
RT   "Gene expression profiling in human fetal liver and identification of
RT   tissue- and developmental-stage-specific genes through compiled
RT   expression profiles and efficient cloning of full-length cDNAs.";
RL   Genome Res. 11:1392-1403(2001).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   TYR-27.
RC   TISSUE=Liver;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JUN-2007) to the EMBL/GenBank/DDBJ databases.
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Liver, and Skeletal muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-455.
RC   TISSUE=Liver;
RA   Menaya J., Parrilla R., Ayuso M.S.;
RL   Submitted (MAR-1995) to the EMBL/GenBank/DDBJ databases.
RN   [17]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-167.
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [18]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-26.
RX   PubMed=2419329;
RA   Urano Y., Watanabe K., Sakai M., Tamaoki T.;
RT   "The human albumin gene. Characterization of the 5' and 3' flanking
RT   regions and the polymorphic gene transcripts.";
RL   J. Biol. Chem. 261:3244-3251(1986).
RN   [19]
RP   PROTEIN SEQUENCE OF 25-609.
RX   PubMed=1225573; DOI=10.1016/0014-5793(75)80242-0;
RA   Meloun B., Moravek L., Kostka V.;
RT   "Complete amino acid sequence of human serum albumin.";
RL   FEBS Lett. 58:134-137(1975).
RN   [20]
RP   PROTEIN SEQUENCE OF 25-609.
RA   Brown J.R., Shockley P., Behrens P.Q.;
RL   (In) Bing D.H. (eds.);
RL   The chemistry and physiology of the human plasma proteins, pp.23-40,
RL   Pergamon Press, New York (1979).
RN   [21]
RP   PROTEIN SEQUENCE OF 25-44 AND 480-499.
RC   TISSUE=Heart;
RX   PubMed=7895732; DOI=10.1002/elps.11501501209;
RA   Corbett J.M., Wheeler C.H., Baker C.S., Yacoub M.H., Dunn M.J.;
RT   "The human myocardial two-dimensional gel protein database: update
RT   1994.";
RL   Electrophoresis 15:1459-1465(1994).
RN   [22]
RP   PROTEIN SEQUENCE OF 25-34.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [23]
RP   PROTEIN SEQUENCE OF 45-75; 98-130; 162-183; 239-254; 265-281; 287-298;
RP   348-372; 397-434; 438-452; 500-543; 550-558; 570-581 AND 599-609, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [24]
RP   PROTEIN SEQUENCE OF 166-174.
RX   PubMed=3087352; DOI=10.1016/0006-291X(86)90429-8;
RA   Mogard M.H., Kobayashi R., Chen C.F., Lee T.D., Reeve J.R. Jr.,
RA   Shively J.E., Walsh J.H.;
RT   "The amino acid sequence of kinetensin, a novel peptide isolated from
RT   pepsin-treated human plasma: homology with human serum albumin,
RT   neurotensin and angiotensin.";
RL   Biochem. Biophys. Res. Commun. 136:983-988(1986).
RN   [25]
RP   PROTEIN SEQUENCE OF 166-174.
RX   PubMed=2437111;
RA   Carraway R.E., Mitra S.P., Cochrane D.E.;
RT   "Structure of a biologically active neurotensin-related peptide
RT   obtained from pepsin-treated albumin(s).";
RL   J. Biol. Chem. 262:5968-5973(1987).
RN   [26]
RP   PROTEIN SEQUENCE OF 222-229, AND ASPIRIN-ACETYLATION AT LYS-223.
RX   PubMed=955075; DOI=10.1016/0014-5793(76)80496-6;
RA   Walker J.E.;
RT   "Lysine residue 199 of human serum albumin is modified by
RT   acetylsalicylic acid.";
RL   FEBS Lett. 66:173-175(1976).
RN   [27]
RP   PROTEIN SEQUENCE OF 250-264, GLYCATION AT LYS-75; LYS-161; LYS-186;
RP   LYS-249; LYS-257; LYS-300; LYS-337; LYS-347; LYS-375; LYS-402;
RP   LYS-437; LYS-468; LYS-560; LYS-549; LYS-569 AND LYS-597, LACK OF
RP   GLYCATION AT LYS-28; LYS-44; LYS-65; LYS-88; LYS-97; LYS-117; LYS-130;
RP   LYS-160; LYS-183; LYS-198; LYS-205; LYS-214; LYS-219; LYS-229;
RP   LYS-236; LYS-264; LYS-286; LYS-298; LYS-310; LYS-383; LYS-396;
RP   LYS-413; LYS-426; LYS-438; LYS-456; LYS-460; LYS-490; LYS-499;
RP   LYS-524; LYS-543; LYS-548; LYS-562; LYS-565; LYS-581; LYS-584; LYS-588
RP   AND LYS-598, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15047055; DOI=10.1016/j.jasms.2003.11.014;
RA   Lapolla A., Fedele D., Reitano R., Arico N.C., Seraglia R., Traldi P.,
RA   Marotta E., Tonani R.;
RT   "Enzymatic digestion and mass spectrometry in the study of advanced
RT   glycation end products/peptides.";
RL   J. Am. Soc. Mass Spectrom. 15:496-509(2004).
RN   [28]
RP   DISULFIDE BONDS.
RA   Saber M.A., Stockbauer P., Moravek L., Meloun B.;
RT   "Disulfide bonds in human serum albumin.";
RL   Collect. Czech. Chem. Commun. 42:564-579(1977).
RN   [29]
RP   BILIRUBIN-BINDING SITE.
RX   PubMed=656055; DOI=10.1042/bj1710453;
RA   Jacobsen C.;
RT   "Lysine residue 240 of human serum albumin is involved in high-
RT   affinity binding of bilirubin.";
RL   Biochem. J. 171:453-459(1978).
RN   [30]
RP   GLYCATION AT LYS-223 AND LYS-549.
RX   PubMed=6853480;
RA   Garlick R.L., Mazer J.S.;
RT   "The principal site of nonenzymatic glycosylation of human serum
RT   albumin in vivo.";
RL   J. Biol. Chem. 258:6142-6146(1983).
RN   [31]
RP   GLYCATION AT LYS-549.
RX   PubMed=6706980;
RA   Shaklai N., Garlick R.L., Bunn H.F.;
RT   "Nonenzymatic glycosylation of human serum albumin alters its
RT   conformation and function.";
RL   J. Biol. Chem. 259:3812-3817(1984).
RN   [32]
RP   GLYCATION AT LYS-36; LYS-223; LYS-257; LYS-305; LYS-341; LYS-375;
RP   LYS-463; LYS-549 AND LYS-558.
RX   PubMed=3759977;
RA   Iberg N., Fluckiger R.;
RT   "Nonenzymatic glycosylation of albumin in vivo. Identification of
RT   multiple glycosylated sites.";
RL   J. Biol. Chem. 261:13542-13545(1986).
RN   [33]
RP   INVOLVEMENT IN ANALBA.
RX   PubMed=8134387; DOI=10.1073/pnas.91.6.2275;
RA   Watkins S., Madison J., Galliano M., Minchiotti L., Putnam F.W.;
RT   "A nucleotide insertion and frameshift cause analbuminemia in an
RT   Italian family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:2275-2279(1994).
RN   [34]
RP   FUNCTION, AND ZINC-BINDING SITES.
RX   PubMed=19021548; DOI=10.1042/BST0361317;
RA   Lu J., Stewart A.J., Sadler P.J., Pinheiro T.J., Blindauer C.A.;
RT   "Albumin as a zinc carrier: properties of its high-affinity zinc-
RT   binding site.";
RL   Biochem. Soc. Trans. 36:1317-1321(2008).
RN   [35]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-443; THR-444 AND
RP   THR-446, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [37]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [38]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82; SER-89 AND SER-513,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [39]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT LYS-558, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [40]
RP   PHOSPHORYLATION AT SER-29; SER-82; SER-89 AND THR-107.
RX   PubMed=26091039; DOI=10.1016/j.cell.2015.05.028;
RA   Tagliabracci V.S., Wiley S.E., Guo X., Kinch L.N., Durrant E., Wen J.,
RA   Xiao J., Cui J., Nguyen K.B., Engel J.L., Coon J.J., Grishin N.,
RA   Pinna L.A., Pagliarini D.J., Dixon J.E.;
RT   "A single kinase generates the majority of the secreted
RT   phosphoproteome.";
RL   Cell 161:1619-1632(2015).
RN   [41]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [42]
RP   X-RAY CRYSTALLOGRAPHY (6.0 ANGSTROMS).
RX   PubMed=2727704; DOI=10.1126/science.2727704;
RA   Carter D.C., He X.-M., Munson S.H., Twigg P.D., Gernert K.M.,
RA   Broom M.B., Miller T.Y.;
RT   "Three-dimensional structure of human serum albumin.";
RL   Science 244:1195-1198(1989).
RN   [43]
RP   X-RAY CRYSTALLOGRAPHY (4.0 ANGSTROMS).
RX   PubMed=2374930; DOI=10.1126/science.2374930;
RA   Carter D.C., He X.-M.;
RT   "Structure of human serum albumin.";
RL   Science 249:302-303(1990).
RN   [44]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS).
RX   PubMed=1630489; DOI=10.1038/358209a0;
RA   He X.-M., Carter D.C.;
RT   "Atomic structure and chemistry of human serum albumin.";
RL   Nature 358:209-215(1992).
RN   [45]
RP   ERRATUM.
RA   He X.-M., Carter D.C.;
RL   Nature 364:362-362(1993).
RN   [46]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
RX   PubMed=9731778; DOI=10.1038/1869;
RA   Curry S., Mandelkow H., Brick P., Franks N.;
RT   "Crystal structure of human serum albumin complexed with fatty acid
RT   reveals an asymmetric distribution of binding sites.";
RL   Nat. Struct. Biol. 5:827-835(1998).
RN   [47]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
RX   PubMed=10388840; DOI=10.1093/protein/12.6.439;
RA   Sugio S., Kashima A., Mochizuki S., Noda M., Kobayashi K.;
RT   "Crystal structure of human serum albumin at 2.5-A resolution.";
RL   Protein Eng. 12:439-446(1999).
RN   [48]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 25-609.
RX   PubMed=10940303; DOI=10.1074/jbc.M005460200;
RA   Bhattacharya A.A., Curry S., Franks N.P.;
RT   "Binding of the general anesthetics propofol and halothane to human
RT   serum albumin. High resolution crystal structures.";
RL   J. Biol. Chem. 275:38731-38738(2000).
RN   [49]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS).
RX   PubMed=11743713; DOI=10.1006/jmbi.2000.5208;
RA   Petitpas I., Grune T., Bhattacharya A.A., Curry S.;
RT   "Crystal structures of human serum albumin complexed with
RT   monounsaturated and polyunsaturated fatty acids.";
RL   J. Mol. Biol. 314:955-960(2001).
RN   [50]
RP   VARIANT CANTERBURY ASN-337.
RX   PubMed=3828358; DOI=10.1016/0167-4838(87)90088-4;
RA   Brennan S.O., Herbert P.;
RT   "Albumin Canterbury (313 Lys-->Asn). A point mutation in the second
RT   domain of serum albumin.";
RL   Biochim. Biophys. Acta 912:191-197(1987).
RN   [51]
RP   VARIANTS NASKAPI/MERSIN GLU-396 AND MEXICO GLY-574.
RX   PubMed=3474609; DOI=10.1073/pnas.84.13.4413;
RA   Takahashi N., Takahashi Y., Blumberg B.S., Putnam F.W.;
RT   "Amino acid substitutions in genetic variants of human serum albumin
RT   and in sequences inferred from molecular cloning.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:4413-4417(1987).
RN   [52]
RP   VARIANTS NAGASAKI-3 GLN-27 YANOMAMA-2 GLU-396; NAGASAKI-2 ASN-399 AND
RP   MAKU GLU-565.
RX   PubMed=3479777; DOI=10.1073/pnas.84.22.8001;
RA   Takshashi N., Takahashi Y., Isobe T., Putnam F.W., Fujita M.,
RA   Satoh C., Neel J.V.;
RT   "Amino acid substitutions in inherited albumin variants from
RT   Amerindian and Japanese populations.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:8001-8005(1987).
RN   [53]
RP   VARIANTS FUKUOKA-2 HIS-23; CHRISTCHURCH/HONOLULU-2 GLN-24; TAGLIACOZZO
RP   ASN-337 AND ALBUMIN B/OSAKA-2/PHNOM PHEN LYS-594.
RX   PubMed=2911589; DOI=10.1073/pnas.86.2.434;
RA   Arai K., Ishioka N., Huss K., Madison J., Putnam F.W.;
RT   "Identical structural changes in inherited albumin variants from
RT   different populations.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:434-438(1989).
RN   [54]
RP   VARIANTS HONOLULU-2 GLN-24; NAGASAKI-1 GLY-293; HIROSHIMA-1 LYS-378;
RP   TOCHIGI LYS-400; HIROSHIMA-2 LYS-406 AND OSAKA-2 LYS-594.
RX   PubMed=2762316; DOI=10.1073/pnas.86.16.6092;
RA   Arai K., Madison J., Huss K., Ishioka N., Satoh C., Fujita M.,
RA   Neel J.V., Sakurabayashi I., Putnam F.W.;
RT   "Point substitutions in Japanese alloalbumins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:6092-6096(1989).
RN   [55]
RP   VARIANTS HONOLULU-1 PRO-24; HONOLULU-2 GLN-24; NAGOYA LYS-143; NEW
RP   GUINEA ASN-337; MANAUS-1/LAMBADI LYS-525; FUKUOKA-1 ASN-587; OSAKA-1
RP   LYS-589 AND OSAKA-2 LYS-594.
RX   PubMed=2404284; DOI=10.1073/pnas.87.1.497;
RA   Arai K., Madison J., Shimuzu A., Putnam F.W.;
RT   "Point substitutions in albumin genetic variants from Asia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:497-501(1990).
RN   [56]
RP   CHARACTERIZATION OF VARIANT REDHILL.
RX   PubMed=2104980; DOI=10.1073/pnas.87.1.26;
RA   Brennan S.O., Myles T., Peach R.J., Donaldson D., George P.M.;
RT   "Albumin Redhill (-1 Arg, 320 Ala-->Thr): a glycoprotein variant of
RT   human serum albumin whose precursor has an aberrant signal peptidase
RT   cleavage site.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:26-30(1990).
RN   [57]
RP   VARIANTS VARESE HIS-23; TORINO LYS-84 AND VIBO VALENTIA LYS-106.
RX   PubMed=2247440; DOI=10.1073/pnas.87.22.8721;
RA   Galliano M., Minchiotti L., Porta F., Rossi A., Ferri G., Madison J.,
RA   Watkins S., Putnam F.W.;
RT   "Mutations in genetic variants of human serum albumin found in
RT   Italy.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:8721-8725(1990).
RN   [58]
RP   CHARACTERIZATION OF VARIANT VENEZIA.
RX   PubMed=2068071; DOI=10.1073/pnas.88.14.5959;
RA   Watkins S., Madison J., Davis E., Sakamoto Y., Galliano M.,
RA   Minchiotti L., Putnam F.W.;
RT   "A donor splice mutation and a single-base deletion produce two
RT   carboxyl-terminal variants of human serum albumin.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:5959-5963(1991).
RN   [59]
RP   VARIANTS KOMAGOME-3 HIS-23; IOWA CITY-2 VAL-25; KOMAGOME-2 ARG-152;
RP   IOWA CITY-1 VAL-389 AND KOMAGOME-1 GLU-396.
RX   PubMed=1946412; DOI=10.1073/pnas.88.21.9853;
RA   Madison J., Arai K., Feld R.D., Kyle R.A., Watkins S., Davis E.,
RA   Matsuda Y., Amaki I., Putnam F.W.;
RT   "Genetic variants of serum albumin in Americans and Japanese.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:9853-9857(1991).
RN   [60]
RP   VARIANT CASEBROOK ASN-518.
RX   PubMed=1859851; DOI=10.1016/0925-4439(91)90023-3;
RA   Peach R.J., Brennan S.O.;
RT   "Structural characterization of a glycoprotein variant of human serum
RT   albumin: albumin Casebrook (494 Asp-->Asn).";
RL   Biochim. Biophys. Acta 1097:49-54(1991).
RN   [61]
RP   VARIANTS SONDRIO LYS-357 AND PARIS-2 ASN-587.
RX   PubMed=1347703; DOI=10.1016/0167-4838(92)90207-T;
RA   Minchiotti L., Galliano M., Stoppini M., Ferri G., Crespeau H.,
RA   Rochu D., Porta F.;
RT   "Two alloalbumins with identical electrophoretic mobility are produced
RT   by differently charged amino acid substitutions.";
RL   Biochim. Biophys. Acta 1119:232-238(1992).
RN   [62]
RP   VARIANTS MALMO-I CYS-23; MALMO-95 ASN-87; MALMO-10 ARG-292; MALMO-47
RP   LYS-342; MALMO-5 GLN-400 AND MALMO-61 ALA-574.
RX   PubMed=1518850; DOI=10.1073/pnas.89.17.8225;
RA   Carlson J., Sakamoto Y., Laurell C.-B., Madison J., Watkins S.,
RA   Putnam F.W.;
RT   "Alloalbuminemia in Sweden: structural study and phenotypic
RT   distribution of nine albumin variants.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:8225-8229(1992).
RN   [63]
RP   VARIANT HERBORN GLU-264.
RX   PubMed=8513793; DOI=10.1111/j.1432-1033.1993.tb17939.x;
RA   Minchiotti L., Galliano M., Zapponi M.C., Tenni R.;
RT   "The structural characterization and bilirubin-binding properties of
RT   albumin Herborn, a [Lys240-->Glu] albumin mutant.";
RL   Eur. J. Biochem. 214:437-444(1993).
RN   [64]
RP   VARIANT HAWKES BAY PHE-201.
RX   PubMed=8347685; DOI=10.1016/0925-4439(93)90151-P;
RA   Brennan S.O., Fellowes A.P.;
RT   "Albumin Hawkes Bay; a low level variant caused by loss of a
RT   sulphydryl group at position 177.";
RL   Biochim. Biophys. Acta 1182:46-50(1993).
RN   [65]
RP   VARIANT ORTONOVO LYS-529.
RX   PubMed=7902134; DOI=10.1016/0925-4439(93)90117-J;
RA   Galliano M., Minchiotti L., Iadarola P., Stoppini M., Giagnoni P.,
RA   Watkins S., Madison J., Putnam F.W.;
RT   "Protein and DNA sequence analysis of a 'private' genetic variant:
RT   albumin Ortonovo (Glu-505-->Lys).";
RL   Biochim. Biophys. Acta 1225:27-32(1993).
RN   [66]
RP   VARIANTS LARINO TYR-27; TRADATE-2 GLN-249 AND CASERTA ASN-300.
RX   PubMed=8022807; DOI=10.1073/pnas.91.14.6476;
RA   Madison J., Galliano M., Watkins S., Minchiotti L., Porta F.,
RA   Rossi A., Putnam F.W.;
RT   "Genetic variants of human serum albumin in Italy: point mutants and a
RT   carboxyl-terminal variant.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:6476-6480(1994).
RN   [67]
RP   VARIANT FDAH HIS-242.
RX   PubMed=8048949; DOI=10.1006/bbrc.1994.1998;
RA   Sunthornthepvarakul T., Angkeow P., Weiss R.E., Hayashi Y.,
RA   Retetoff S.;
RT   "An identical missense mutation in the albumin gene results in
RT   familial dysalbuminemic hyperthyroxinemia in 8 unrelated families.";
RL   Biochem. Biophys. Res. Commun. 202:781-787(1994).
RN   [68]
RP   VARIANT FDAH HIS-242, AND PROTEIN SEQUENCE OF 25-51.
RX   PubMed=7852505; DOI=10.1210/jcem.80.2.7852505;
RA   Rushbrook J.I., Becker E., Schussler G.C., Divino C.M.;
RT   "Identification of a human serum albumin species associated with
RT   familial dysalbuminemic hyperthyroxinemia.";
RL   J. Clin. Endocrinol. Metab. 80:461-467(1995).
RN   [69]
RP   VARIANT FDAH HIS-242.
RX   PubMed=9329347; DOI=10.1210/jcem.82.10.4276;
RA   Wada N., Chiba H., Shimizu C., Kijima H., Kubo M., Koike T.;
RT   "A novel missense mutation in codon 218 of the albumin gene in a
RT   distinct phenotype of familial dysalbuminemic hyperthyroxinemia in a
RT   Japanese kindred.";
RL   J. Clin. Endocrinol. Metab. 82:3246-3250(1997).
RN   [70]
RP   VARIANT FDAH PRO-90.
RX   PubMed=9589637; DOI=10.1210/jcem.83.5.4815;
RA   Sunthornthepvarakul T., Likitmaskul S., Ngowngarmratana S.,
RA   Angsusingha K., Kitvitayasak S., Scherberg N.H., Refetoff S.;
RT   "Familial dysalbuminemic hypertriiodothyroninemia: a new, dominantly
RT   inherited albumin defect.";
RL   J. Clin. Endocrinol. Metab. 83:1448-1454(1998).
RN   [71]
RP   VARIANT TYR-73, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Urine;
RX   PubMed=11680902;
RX   DOI=10.1002/1615-9861(200101)1:1<93::AID-PROT93>3.0.CO;2-3;
RA   Spahr C.S., Davis M.T., McGinley M.D., Robinson J.H., Bures E.J.,
RA   Beierle J., Mort J., Courchesne P.L., Chen K., Wahl R.C., Yu W.,
RA   Luethy R., Patterson S.D.;
RT   "Towards defining the urinary proteome using liquid chromatography-
RT   tandem mass spectrometry I. Profiling an unfractionated tryptic
RT   digest.";
RL   Proteomics 1:93-107(2001).
RN   [72]
RP   CHARACTERIZATION OF VARIANT KENITRA.
RX   PubMed=11168369; DOI=10.1046/j.1432-1033.2001.01899.x;
RA   Minchiotti L., Campagnoli M., Rossi A., Cosulich M.E., Monti M.,
RA   Pucci P., Kragh-Hansen U., Granel B., Disdier P., Weiller P.J.,
RA   Galliano M.;
RT   "A nucleotide insertion and frameshift cause albumin Kenitra, an
RT   extended and O-glycosylated mutant of human serum albumin with two
RT   additional disulfide bridges.";
RL   Eur. J. Biochem. 268:344-352(2001).
CC   -!- FUNCTION: Serum albumin, the main protein of plasma, has a good
CC       binding capacity for water, Ca(2+), Na(+), K(+), fatty acids,
CC       hormones, bilirubin and drugs. Its main function is the regulation
CC       of the colloidal osmotic pressure of blood. Major zinc transporter
CC       in plasma, typically binds about 80% of all plasma zinc.
CC       {ECO:0000269|PubMed:19021548}.
CC   -!- INTERACTION:
CC       Self; NbExp=8; IntAct=EBI-714423, EBI-714423;
CC       P02786:TFRC; NbExp=2; IntAct=EBI-714423, EBI-355727;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P02768-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P02768-2; Sequence=VSP_021275;
CC       Name=3;
CC         IsoId=P02768-3; Sequence=VSP_057389;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Plasma.
CC   -!- PTM: Kenitra variant is partially O-glycosylated at Thr-620. It
CC       has two new disulfide bonds Cys-600 to Cys-602 and Cys-601 to Cys-
CC       606.
CC   -!- PTM: Glycated in diabetic patients.
CC   -!- PTM: Phosphorylated by FAM20C in the extracellular medium.
CC       {ECO:0000269|PubMed:26091039}.
CC   -!- PTM: Acetylated on Lys-223 by acetylsalicylic acid.
CC   -!- POLYMORPHISM: A variant structure of albumin could lead to
CC       increased binding of zinc resulting in an asymptomatic
CC       augmentation of zinc concentration in the blood. The sequence
CC       shown is that of variant albumin A.
CC   -!- DISEASE: Hyperthyroxinemia, familial dysalbuminemic (FDAH)
CC       [MIM:615999]: A disorder characterized by abnormally elevated
CC       levels of total serum thyroxine (T4) in euthyroid patients. It is
CC       due to abnormal serum albumin that binds T4 with enhanced
CC       affinity. {ECO:0000269|PubMed:7852505, ECO:0000269|PubMed:8048949,
CC       ECO:0000269|PubMed:9329347, ECO:0000269|PubMed:9589637}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Analbuminemia (ANALBA) [MIM:616000]: A rare autosomal
CC       recessive disorder manifested by the presence of a very low amount
CC       of circulating serum albumin. Affected individuals manifest mild
CC       edema, hypotension, fatigue, and, occasionally, lower body
CC       lipodystrophy (mainly in adult females). The most common
CC       biochemical finding is hyperlipidemia, with a significant increase
CC       in the total and LDL cholesterol concentrations, but normal
CC       concentrations of HDL cholesterol and triglycerides.
CC       {ECO:0000269|PubMed:8134387}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ALB/AFP/VDB family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00769}.
CC   -!- CAUTION: A peptide arising from positions 166 to 174 was
CC       originally (PubMed:3087352 and PubMed:2437111) termed neurotensin-
CC       related peptide (NRP) or kinetensin and was thought to regulate
CC       fat digestion, lipid absorption, and blood flow. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF22034.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAF69644.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAG35503.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Albumin Website;
CC       URL="http://albumin.org";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Serum albumin entry;
CC       URL="https://en.wikipedia.org/wiki/Serum_albumin";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/alb/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; V00494; CAA23753.1; -; mRNA.
DR   EMBL; V00495; CAA23754.1; -; mRNA.
DR   EMBL; M12523; AAA98797.1; -; Genomic_DNA.
DR   EMBL; M12523; AAA98798.1; -; Genomic_DNA.
DR   EMBL; AF190168; AAF01333.1; -; mRNA.
DR   EMBL; AF542069; AAN17825.1; -; mRNA.
DR   EMBL; A06977; CAA00606.1; -; mRNA.
DR   EMBL; AY728024; AAU21642.1; -; mRNA.
DR   EMBL; DQ986150; ABJ16448.1; -; mRNA.
DR   EMBL; AY544124; AAT11155.1; -; mRNA.
DR   EMBL; AY550967; AAT52213.1; -; mRNA.
DR   EMBL; AF116645; AAF71067.1; -; mRNA.
DR   EMBL; AF118090; AAF22034.1; ALT_INIT; mRNA.
DR   EMBL; AF119840; AAF69594.1; -; mRNA.
DR   EMBL; AF119890; AAF69644.1; ALT_INIT; mRNA.
DR   EMBL; AF130077; AAG35503.1; ALT_INIT; mRNA.
DR   EMBL; CR749331; CAH18185.1; -; mRNA.
DR   EMBL; EF649953; ABS29264.1; -; Genomic_DNA.
DR   EMBL; AC108157; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471057; EAX05676.1; -; Genomic_DNA.
DR   EMBL; BC014308; AAH14308.1; -; mRNA.
DR   EMBL; BC034023; AAH34023.1; -; mRNA.
DR   EMBL; BC035969; AAH35969.1; -; mRNA.
DR   EMBL; BC036003; AAH36003.1; -; mRNA.
DR   EMBL; BC041789; AAH41789.1; -; mRNA.
DR   EMBL; U22961; AAA64922.1; -; mRNA.
DR   EMBL; AY358313; AAQ89947.1; -; mRNA.
DR   EMBL; AH002596; AAA51688.1; -; Genomic_DNA.
DR   CCDS; CCDS3555.1; -. [P02768-1]
DR   PIR; A93743; ABHUS.
DR   RefSeq; NP_000468.1; NM_000477.6. [P02768-1]
DR   UniGene; Hs.418167; -.
DR   UniGene; Hs.592379; -.
DR   PDB; 1AO6; X-ray; 2.50 A; A/B=25-609.
DR   PDB; 1BJ5; X-ray; 2.50 A; A=25-609.
DR   PDB; 1BKE; X-ray; 3.15 A; A=28-608.
DR   PDB; 1BM0; X-ray; 2.50 A; A/B=25-609.
DR   PDB; 1E78; X-ray; 2.60 A; A/B=25-609.
DR   PDB; 1E7A; X-ray; 2.20 A; A/B=25-609.
DR   PDB; 1E7B; X-ray; 2.38 A; A/B=25-609.
DR   PDB; 1E7C; X-ray; 2.40 A; A=25-609.
DR   PDB; 1E7E; X-ray; 2.50 A; A=25-609.
DR   PDB; 1E7F; X-ray; 2.43 A; A=25-609.
DR   PDB; 1E7G; X-ray; 2.50 A; A=25-609.
DR   PDB; 1E7H; X-ray; 2.43 A; A=25-609.
DR   PDB; 1E7I; X-ray; 2.70 A; A=25-609.
DR   PDB; 1GNI; X-ray; 2.40 A; A=25-609.
DR   PDB; 1GNJ; X-ray; 2.60 A; A=25-609.
DR   PDB; 1H9Z; X-ray; 2.50 A; A=25-609.
DR   PDB; 1HA2; X-ray; 2.50 A; A=25-609.
DR   PDB; 1HK1; X-ray; 2.65 A; A=25-609.
DR   PDB; 1HK2; X-ray; 2.80 A; A=25-609.
DR   PDB; 1HK3; X-ray; 2.80 A; A=25-609.
DR   PDB; 1HK4; X-ray; 2.40 A; A=25-609.
DR   PDB; 1HK5; X-ray; 2.70 A; A=25-609.
DR   PDB; 1N5U; X-ray; 1.90 A; A=25-609.
DR   PDB; 1O9X; X-ray; 3.20 A; A=25-609.
DR   PDB; 1TF0; X-ray; 2.70 A; A=25-596.
DR   PDB; 1UOR; X-ray; 2.80 A; A=25-609.
DR   PDB; 1YSX; NMR; -; A=409-609.
DR   PDB; 2BX8; X-ray; 2.70 A; A/B=25-609.
DR   PDB; 2BXA; X-ray; 2.35 A; A/B=25-609.
DR   PDB; 2BXB; X-ray; 3.20 A; A/B=25-609.
DR   PDB; 2BXC; X-ray; 3.10 A; A/B=25-609.
DR   PDB; 2BXD; X-ray; 3.05 A; A/B=25-609.
DR   PDB; 2BXE; X-ray; 2.95 A; A/B=25-609.
DR   PDB; 2BXF; X-ray; 2.95 A; A/B=25-609.
DR   PDB; 2BXG; X-ray; 2.70 A; A/B=25-609.
DR   PDB; 2BXH; X-ray; 2.25 A; A/B=25-609.
DR   PDB; 2BXI; X-ray; 2.50 A; A=25-609.
DR   PDB; 2BXK; X-ray; 2.40 A; A=25-609.
DR   PDB; 2BXL; X-ray; 2.60 A; A=25-609.
DR   PDB; 2BXM; X-ray; 2.50 A; A=25-609.
DR   PDB; 2BXN; X-ray; 2.65 A; A=25-609.
DR   PDB; 2BXO; X-ray; 2.60 A; A=25-609.
DR   PDB; 2BXP; X-ray; 2.30 A; A=25-609.
DR   PDB; 2BXQ; X-ray; 2.60 A; A=25-609.
DR   PDB; 2ESG; X-ray; -; C=25-609.
DR   PDB; 2I2Z; X-ray; 2.70 A; A=25-609.
DR   PDB; 2I30; X-ray; 2.90 A; A=25-609.
DR   PDB; 2N0X; NMR; -; A=432-447.
DR   PDB; 2VDB; X-ray; 2.52 A; A=30-608.
DR   PDB; 2VUE; X-ray; 2.42 A; A/B=25-609.
DR   PDB; 2VUF; X-ray; 3.05 A; A/B=25-609.
DR   PDB; 2XSI; X-ray; 2.70 A; A=25-609.
DR   PDB; 2XVQ; X-ray; 2.90 A; A/B=25-609.
DR   PDB; 2XVU; X-ray; 2.60 A; A/B=25-609.
DR   PDB; 2XVV; X-ray; 2.40 A; A=25-609.
DR   PDB; 2XVW; X-ray; 2.65 A; A=25-609.
DR   PDB; 2XW0; X-ray; 2.40 A; A/B=25-609.
DR   PDB; 2XW1; X-ray; 2.50 A; A/B=25-609.
DR   PDB; 2YDF; X-ray; 2.75 A; A/B=25-609.
DR   PDB; 3A73; X-ray; 2.19 A; A/B=25-609.
DR   PDB; 3B9L; X-ray; 2.60 A; A=25-609.
DR   PDB; 3B9M; X-ray; 2.70 A; A=25-609.
DR   PDB; 3CX9; X-ray; 2.80 A; A=27-608.
DR   PDB; 3JQZ; X-ray; 3.30 A; A/B=25-609.
DR   PDB; 3JRY; X-ray; 2.30 A; A/B=25-609.
DR   PDB; 3LU6; X-ray; 2.70 A; A/B=25-609.
DR   PDB; 3LU7; X-ray; 2.80 A; A/B=25-609.
DR   PDB; 3LU8; X-ray; 2.60 A; A/B=25-609.
DR   PDB; 3SQJ; X-ray; 2.05 A; A/B=27-608.
DR   PDB; 3TDL; X-ray; 2.60 A; A=25-609.
DR   PDB; 3UIV; X-ray; 2.20 A; A/H=25-609.
DR   PDB; 4BKE; X-ray; 2.35 A; A=1-609.
DR   PDB; 4E99; X-ray; 2.30 A; A=25-609.
DR   PDB; 4EMX; X-ray; 2.30 A; A/B=25-609.
DR   PDB; 4G03; X-ray; 2.22 A; A/B=25-609.
DR   PDB; 4G04; X-ray; 2.30 A; A/B=25-609.
DR   PDB; 4HGK; X-ray; 3.04 A; A/B=25-609.
DR   PDB; 4HGM; X-ray; 2.34 A; B=25-609.
DR   PDB; 4IW1; X-ray; 2.56 A; A=25-609.
DR   PDB; 4IW2; X-ray; 2.41 A; A=25-609.
DR   PDB; 4K2C; X-ray; 3.23 A; A/B=25-609.
DR   PDB; 4K71; X-ray; 2.40 A; A/D=25-609.
DR   PDB; 4L8U; X-ray; 2.01 A; A=25-609.
DR   PDB; 4L9K; X-ray; 2.40 A; A/B=25-609.
DR   PDB; 4L9Q; X-ray; 2.70 A; A/B=25-609.
DR   PDB; 4LA0; X-ray; 2.40 A; A/B=25-609.
DR   PDB; 4LB2; X-ray; 2.80 A; A/B=25-609.
DR   PDB; 4LB9; X-ray; 2.70 A; A=25-609.
DR   PDB; 4N0F; X-ray; 3.02 A; D/G/J/M=25-609.
DR   PDB; 4N0U; X-ray; 3.80 A; D=27-609.
DR   PDB; 4S1Y; X-ray; 3.16 A; A=25-609.
DR   PDB; 4Z69; X-ray; 2.19 A; A/I=25-609.
DR   PDB; 5FUO; X-ray; 3.60 A; A=25-609.
DR   PDB; 5ID7; X-ray; 2.26 A; A/B=25-609.
DR   PDB; 5IFO; X-ray; 3.20 A; A=25-609.
DR   PDB; 5IJF; X-ray; 2.65 A; A=25-609.
DR   PDBsum; 1AO6; -.
DR   PDBsum; 1BJ5; -.
DR   PDBsum; 1BKE; -.
DR   PDBsum; 1BM0; -.
DR   PDBsum; 1E78; -.
DR   PDBsum; 1E7A; -.
DR   PDBsum; 1E7B; -.
DR   PDBsum; 1E7C; -.
DR   PDBsum; 1E7E; -.
DR   PDBsum; 1E7F; -.
DR   PDBsum; 1E7G; -.
DR   PDBsum; 1E7H; -.
DR   PDBsum; 1E7I; -.
DR   PDBsum; 1GNI; -.
DR   PDBsum; 1GNJ; -.
DR   PDBsum; 1H9Z; -.
DR   PDBsum; 1HA2; -.
DR   PDBsum; 1HK1; -.
DR   PDBsum; 1HK2; -.
DR   PDBsum; 1HK3; -.
DR   PDBsum; 1HK4; -.
DR   PDBsum; 1HK5; -.
DR   PDBsum; 1N5U; -.
DR   PDBsum; 1O9X; -.
DR   PDBsum; 1TF0; -.
DR   PDBsum; 1UOR; -.
DR   PDBsum; 1YSX; -.
DR   PDBsum; 2BX8; -.
DR   PDBsum; 2BXA; -.
DR   PDBsum; 2BXB; -.
DR   PDBsum; 2BXC; -.
DR   PDBsum; 2BXD; -.
DR   PDBsum; 2BXE; -.
DR   PDBsum; 2BXF; -.
DR   PDBsum; 2BXG; -.
DR   PDBsum; 2BXH; -.
DR   PDBsum; 2BXI; -.
DR   PDBsum; 2BXK; -.
DR   PDBsum; 2BXL; -.
DR   PDBsum; 2BXM; -.
DR   PDBsum; 2BXN; -.
DR   PDBsum; 2BXO; -.
DR   PDBsum; 2BXP; -.
DR   PDBsum; 2BXQ; -.
DR   PDBsum; 2ESG; -.
DR   PDBsum; 2I2Z; -.
DR   PDBsum; 2I30; -.
DR   PDBsum; 2N0X; -.
DR   PDBsum; 2VDB; -.
DR   PDBsum; 2VUE; -.
DR   PDBsum; 2VUF; -.
DR   PDBsum; 2XSI; -.
DR   PDBsum; 2XVQ; -.
DR   PDBsum; 2XVU; -.
DR   PDBsum; 2XVV; -.
DR   PDBsum; 2XVW; -.
DR   PDBsum; 2XW0; -.
DR   PDBsum; 2XW1; -.
DR   PDBsum; 2YDF; -.
DR   PDBsum; 3A73; -.
DR   PDBsum; 3B9L; -.
DR   PDBsum; 3B9M; -.
DR   PDBsum; 3CX9; -.
DR   PDBsum; 3JQZ; -.
DR   PDBsum; 3JRY; -.
DR   PDBsum; 3LU6; -.
DR   PDBsum; 3LU7; -.
DR   PDBsum; 3LU8; -.
DR   PDBsum; 3SQJ; -.
DR   PDBsum; 3TDL; -.
DR   PDBsum; 3UIV; -.
DR   PDBsum; 4BKE; -.
DR   PDBsum; 4E99; -.
DR   PDBsum; 4EMX; -.
DR   PDBsum; 4G03; -.
DR   PDBsum; 4G04; -.
DR   PDBsum; 4HGK; -.
DR   PDBsum; 4HGM; -.
DR   PDBsum; 4IW1; -.
DR   PDBsum; 4IW2; -.
DR   PDBsum; 4K2C; -.
DR   PDBsum; 4K71; -.
DR   PDBsum; 4L8U; -.
DR   PDBsum; 4L9K; -.
DR   PDBsum; 4L9Q; -.
DR   PDBsum; 4LA0; -.
DR   PDBsum; 4LB2; -.
DR   PDBsum; 4LB9; -.
DR   PDBsum; 4N0F; -.
DR   PDBsum; 4N0U; -.
DR   PDBsum; 4S1Y; -.
DR   PDBsum; 4Z69; -.
DR   PDBsum; 5FUO; -.
DR   PDBsum; 5ID7; -.
DR   PDBsum; 5IFO; -.
DR   PDBsum; 5IJF; -.
DR   ProteinModelPortal; P02768; -.
DR   SMR; P02768; -.
DR   BioGrid; 106715; 183.
DR   DIP; DIP-29902N; -.
DR   IntAct; P02768; 171.
DR   MINT; MINT-3004222; -.
DR   STRING; 9606.ENSP00000295897; -.
DR   BindingDB; P02768; -.
DR   ChEMBL; CHEMBL3253; -.
DR   DrugBank; DB07517; 3-CARBOXY-4-METHYL-5-PROPYL-2-FURANPROPIONIC.
DR   DrugBank; DB07992; 3-SULFOOXY-1H-INDOLE.
DR   DrugBank; DB05812; Abiraterone.
DR   DrugBank; DB01418; Acenocoumarol.
DR   DrugBank; DB01614; Acepromazine.
DR   DrugBank; DB00945; Acetylsalicylic acid.
DR   DrugBank; DB00459; Acitretin.
DR   DrugBank; DB00802; Alfentanil.
DR   DrugBank; DB00321; Amitriptyline.
DR   DrugBank; DB00415; Ampicillin.
DR   DrugBank; DB04557; Arachidonic Acid.
DR   DrugBank; DB00995; Auranofin.
DR   DrugBank; DB07402; Azapropazone.
DR   DrugBank; DB01294; Bismuth Subsalicylate.
DR   DrugBank; DB08907; Canagliflozin.
DR   DrugBank; DB01197; Captopril.
DR   DrugBank; DB00456; Cefalotin.
DR   DrugBank; DB01327; Cefazolin.
DR   DrugBank; DB00274; Cefmetazole.
DR   DrugBank; DB01328; Cefonicid.
DR   DrugBank; DB01329; Cefoperazone.
DR   DrugBank; DB00493; Cefotaxime.
DR   DrugBank; DB01330; Cefotetan.
DR   DrugBank; DB00430; Cefpiramide.
DR   DrugBank; DB01212; Ceftriaxone.
DR   DrugBank; DB00482; Celecoxib.
DR   DrugBank; DB00567; Cephalexin.
DR   DrugBank; DB00477; Chlorpromazine.
DR   DrugBank; DB01242; Clomipramine.
DR   DrugBank; DB01068; Clonazepam.
DR   DrugBank; DB01147; Cloxacillin.
DR   DrugBank; DB03600; Decanoic Acid.
DR   DrugBank; DB01189; Desflurane.
DR   DrugBank; DB00829; Diazepam.
DR   DrugBank; DB00586; Diclofenac.
DR   DrugBank; DB00861; Diflunisal.
DR   DrugBank; DB01396; Digitoxin.
DR   DrugBank; DB04855; Dronedarone.
DR   DrugBank; DB00228; Enflurane.
DR   DrugBank; DB08899; Enzalutamide.
DR   DrugBank; DB00530; Erlotinib.
DR   DrugBank; DB00199; Erythromycin.
DR   DrugBank; DB00783; Estradiol.
DR   DrugBank; DB00655; Estrone.
DR   DrugBank; DB04574; Estrone sulfate.
DR   DrugBank; DB00903; Etacrynic acid.
DR   DrugBank; DB00749; Etodolac.
DR   DrugBank; DB00573; Fenoprofen.
DR   DrugBank; DB00544; Fluorouracil.
DR   DrugBank; DB00472; Fluoxetine.
DR   DrugBank; DB00712; Flurbiprofen.
DR   DrugBank; DB01320; Fosphenytoin.
DR   DrugBank; DB06716; Fospropofol.
DR   DrugBank; DB00695; Furosemide.
DR   DrugBank; DB00743; Gadobenic acid.
DR   DrugBank; DB06705; Gadofosveset trisodium.
DR   DrugBank; DB01044; Gatifloxacin.
DR   DrugBank; DB00317; Gefitinib.
DR   DrugBank; DB01120; Gliclazide.
DR   DrugBank; DB01016; Glyburide.
DR   DrugBank; DB01159; Halothane.
DR   DrugBank; DB00070; Hyaluronidase.
DR   DrugBank; DB06205; Hyaluronidase (Human Recombinant).
DR   DrugBank; DB01050; Ibuprofen.
DR   DrugBank; DB00619; Imatinib.
DR   DrugBank; DB00328; Indomethacin.
DR   DrugBank; DB01307; Insulin Detemir.
DR   DrugBank; DB04711; Iodipamide.
DR   DrugBank; DB00762; Irinotecan.
DR   DrugBank; DB00753; Isoflurane.
DR   DrugBank; DB08820; Ivacaftor.
DR   DrugBank; DB01587; Ketazolam.
DR   DrugBank; DB01009; Ketoprofen.
DR   DrugBank; DB03017; Lauric Acid.
DR   DrugBank; DB00451; Levothyroxine.
DR   DrugBank; DB00279; Liothyronine.
DR   DrugBank; DB01583; Liotrix.
DR   DrugBank; DB00678; Losartan.
DR   DrugBank; DB09280; Lumacaftor.
DR   DrugBank; DB08932; Macitentan.
DR   DrugBank; DB01397; Magnesium salicylate.
DR   DrugBank; DB00931; Methacycline.
DR   DrugBank; DB00563; Methotrexate.
DR   DrugBank; DB06710; Methyltestosterone.
DR   DrugBank; DB08893; Mirabegron.
DR   DrugBank; DB00688; Mycophenolate mofetil.
DR   DrugBank; DB08231; MYRISTIC ACID.
DR   DrugBank; DB01183; Naloxone.
DR   DrugBank; DB00788; Naproxen.
DR   DrugBank; DB00731; Nateglinide.
DR   DrugBank; DB00717; Norethisterone.
DR   DrugBank; DB00540; Nortriptyline.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB04224; Oleic Acid.
DR   DrugBank; DB00776; Oxcarbazepine.
DR   DrugBank; DB06412; Oxymetholone.
DR   DrugBank; DB03585; Oxyphenbutazone.
DR   DrugBank; DB03796; Palmitic Acid.
DR   DrugBank; DB00454; Pethidine.
DR   DrugBank; DB00946; Phenprocoumon.
DR   DrugBank; DB00252; Phenytoin.
DR   DrugBank; DB01621; Pipotiazine.
DR   DrugBank; DB00554; Piroxicam.
DR   DrugBank; DB08860; Pitavastatin.
DR   DrugBank; DB06209; Prasugrel.
DR   DrugBank; DB00635; Prednisone.
DR   DrugBank; DB01032; Probenecid.
DR   DrugBank; DB00818; Propofol.
DR   DrugBank; DB00912; Repaglinide.
DR   DrugBank; DB01045; Rifampicin.
DR   DrugBank; DB08931; Riociguat.
DR   DrugBank; DB00412; Rosiglitazone.
DR   DrugBank; DB01098; Rosuvastatin.
DR   DrugBank; DB06201; Rufinamide.
DR   DrugBank; DB00936; Salicylic acid.
DR   DrugBank; DB01232; Saquinavir.
DR   DrugBank; DB01236; Sevoflurane.
DR   DrugBank; DB06290; Simeprevir.
DR   DrugBank; DB00815; Sodium lauryl sulfate.
DR   DrugBank; DB03193; Stearic acid.
DR   DrugBank; DB00364; Sucralfate.
DR   DrugBank; DB01581; Sulfamerazine.
DR   DrugBank; DB01582; Sulfamethazine.
DR   DrugBank; DB00576; Sulfamethizole.
DR   DrugBank; DB01015; Sulfamethoxazole.
DR   DrugBank; DB00605; Sulindac.
DR   DrugBank; DB00864; Tacrolimus.
DR   DrugBank; DB05521; Telaprevir.
DR   DrugBank; DB00624; Testosterone.
DR   DrugBank; DB00759; Tetracycline.
DR   DrugBank; DB01622; Thioproperazine.
DR   DrugBank; DB01623; Thiothixene.
DR   DrugBank; DB01056; Tocainide.
DR   DrugBank; DB08895; Tofacitinib.
DR   DrugBank; DB08867; Ulipristal.
DR   DrugBank; DB00177; Valsartan.
DR   DrugBank; DB00512; Vancomycin.
DR   DrugBank; DB05294; Vandetanib.
DR   DrugBank; DB08881; Vemurafenib.
DR   DrugBank; DB08828; Vismodegib.
DR   DrugBank; DB00682; Warfarin.
DR   DrugBank; DB00137; Xanthophyll.
DR   DrugBank; DB00495; Zidovudine.
DR   Allergome; 763; Hom s HSA.
DR   iPTMnet; P02768; -.
DR   PhosphoSitePlus; P02768; -.
DR   SwissPalm; P02768; -.
DR   UniCarbKB; P02768; -.
DR   BioMuta; ALB; -.
DR   DMDM; 113576; -.
DR   DOSAC-COBS-2DPAGE; P02768; -.
DR   OGP; P02768; -.
DR   REPRODUCTION-2DPAGE; IPI00384697; -.
DR   REPRODUCTION-2DPAGE; IPI00745872; -.
DR   REPRODUCTION-2DPAGE; P02768; -.
DR   SWISS-2DPAGE; P02768; -.
DR   UCD-2DPAGE; P02768; -.
DR   PaxDb; P02768; -.
DR   PeptideAtlas; P02768; -.
DR   PRIDE; P02768; -.
DR   DNASU; 213; -.
DR   Ensembl; ENST00000295897; ENSP00000295897; ENSG00000163631. [P02768-1]
DR   Ensembl; ENST00000621085; ENSP00000483421; ENSG00000163631. [P02768-3]
DR   GeneID; 213; -.
DR   KEGG; hsa:213; -.
DR   UCSC; uc003hgs.5; human. [P02768-1]
DR   UCSC; uc062xfr.1; human.
DR   CTD; 213; -.
DR   DisGeNET; 213; -.
DR   GeneCards; ALB; -.
DR   HGNC; HGNC:399; ALB.
DR   HPA; CAB006262; -.
DR   HPA; HPA031024; -.
DR   HPA; HPA031025; -.
DR   MalaCards; ALB; -.
DR   MIM; 103600; gene.
DR   MIM; 615999; phenotype.
DR   MIM; 616000; phenotype.
DR   neXtProt; NX_P02768; -.
DR   OpenTargets; ENSG00000163631; -.
DR   Orphanet; 86816; Congenital analbuminemia.
DR   Orphanet; 276271; Familial dysalbuminemic hyperthyroxinemia.
DR   PharmGKB; PA24690; -.
DR   eggNOG; ENOG410IIRZ; Eukaryota.
DR   eggNOG; ENOG410Z40H; LUCA.
DR   GeneTree; ENSGT00390000000113; -.
DR   HOGENOM; HOG000293137; -.
DR   HOVERGEN; HBG004207; -.
DR   InParanoid; P02768; -.
DR   KO; K16141; -.
DR   OMA; EPERNEC; -.
DR   OrthoDB; EOG091G0F5F; -.
DR   PhylomeDB; P02768; -.
DR   TreeFam; TF335561; -.
DR   Reactome; R-HSA-114608; Platelet degranulation.
DR   Reactome; R-HSA-159418; Recycling of bile acids and salts.
DR   Reactome; R-HSA-194223; HDL-mediated lipid transport.
DR   Reactome; R-HSA-2168880; Scavenging of heme from plasma.
DR   Reactome; R-HSA-5619058; Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR).
DR   Reactome; R-HSA-5619110; Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR).
DR   Reactome; R-HSA-879518; Transport of organic anions.
DR   SIGNOR; P02768; -.
DR   ChiTaRS; ALB; human.
DR   EvolutionaryTrace; P02768; -.
DR   GeneWiki; Serum_albumin; -.
DR   GenomeRNAi; 213; -.
DR   PMAP-CutDB; P02768; -.
DR   PRO; PR:P02768; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000163631; -.
DR   ExpressionAtlas; P02768; baseline and differential.
DR   Genevisible; P02768; HS.
DR   GO; GO:0072562; C:blood microparticle; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0043209; C:myelin sheath; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0031093; C:platelet alpha granule lumen; TAS:Reactome.
DR   GO; GO:0043234; C:protein complex; IDA:UniProtKB.
DR   GO; GO:0016209; F:antioxidant activity; NAS:UniProtKB.
DR   GO; GO:0051087; F:chaperone binding; IPI:BHF-UCL.
DR   GO; GO:0005507; F:copper ion binding; NAS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0008144; F:drug binding; IDA:UniProtKB.
DR   GO; GO:0005504; F:fatty acid binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IDA:UniProtKB.
DR   GO; GO:0015643; F:toxic substance binding; IDA:UniProtKB.
DR   GO; GO:0015721; P:bile acid and bile salt transport; TAS:Reactome.
DR   GO; GO:0009267; P:cellular response to starvation; IDA:UniProtKB.
DR   GO; GO:0019836; P:hemolysis by symbiont of host erythrocytes; IDA:UniProtKB.
DR   GO; GO:0042157; P:lipoprotein metabolic process; TAS:Reactome.
DR   GO; GO:0051659; P:maintenance of mitochondrion location; IDA:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0043069; P:negative regulation of programmed cell death; NAS:UniProtKB.
DR   GO; GO:0002576; P:platelet degranulation; TAS:Reactome.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; TAS:Reactome.
DR   GO; GO:0001895; P:retina homeostasis; IEP:UniProtKB.
DR   GO; GO:0043252; P:sodium-independent organic anion transport; TAS:Reactome.
DR   GO; GO:0006810; P:transport; TAS:UniProtKB.
DR   CDD; cd00015; ALBUMIN; 3.
DR   InterPro; IPR000264; ALB/AFP/VDB.
DR   InterPro; IPR020858; Serum_albumin-like.
DR   InterPro; IPR021177; Serum_albumin/AFP/Afamin.
DR   InterPro; IPR020857; Serum_albumin_CS.
DR   InterPro; IPR014760; Serum_albumin_N.
DR   PANTHER; PTHR11385; PTHR11385; 1.
DR   Pfam; PF00273; Serum_albumin; 3.
DR   PIRSF; PIRSF002520; Serum_albumin_subgroup; 1.
DR   PRINTS; PR00802; SERUMALBUMIN.
DR   SMART; SM00103; ALBUMIN; 3.
DR   SUPFAM; SSF48552; SSF48552; 3.
DR   PROSITE; PS00212; ALBUMIN_1; 3.
DR   PROSITE; PS51438; ALBUMIN_2; 3.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing;
KW   Cleavage on pair of basic residues; Complete proteome; Copper;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Glycation; Glycoprotein; Lipid-binding; Metal-binding; Methylation;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; Secreted;
KW   Signal; Zinc.
FT   SIGNAL        1     18
FT   PROPEP       19     24
FT                                /FTId=PRO_0000001067.
FT   CHAIN        25    609       Serum albumin.
FT                                /FTId=PRO_0000001068.
FT   DOMAIN       19    210       Albumin 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00769}.
FT   DOMAIN      211    403       Albumin 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00769}.
FT   DOMAIN      404    601       Albumin 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00769}.
FT   METAL        27     27       Copper. {ECO:0000250}.
FT   METAL        91     91       Zinc.
FT   METAL       123    123       Zinc.
FT   METAL       271    271       Zinc.
FT   METAL       273    273       Zinc.
FT   BINDING     264    264       Bilirubin.
FT   SITE         28     28       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE         44     44       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE         65     65       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE         88     88       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE         97     97       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        117    117       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        130    130       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        160    160       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        183    183       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        198    198       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        205    205       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        214    214       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        219    219       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        223    223       Aspirin-acetylated lysine.
FT   SITE        229    229       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        236    236       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        264    264       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        286    286       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        298    298       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        310    310       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        383    383       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        396    396       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        413    413       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        426    426       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        438    438       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        456    456       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        460    460       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        490    490       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        499    499       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        524    524       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        543    543       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        548    548       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        562    562       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        565    565       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        581    581       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        584    584       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        588    588       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   SITE        598    598       Not glycated.
FT                                {ECO:0000269|PubMed:15047055}.
FT   MOD_RES      29     29       Phosphoserine; by FAM20C.
FT                                {ECO:0000269|PubMed:26091039}.
FT   MOD_RES      82     82       Phosphoserine; by FAM20C.
FT                                {ECO:0000244|PubMed:18318008,
FT                                ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:26091039}.
FT   MOD_RES      89     89       Phosphoserine; by FAM20C.
FT                                {ECO:0000244|PubMed:24275569,
FT                                ECO:0000269|PubMed:26091039}.
FT   MOD_RES     107    107       Phosphothreonine; by FAM20C.
FT                                {ECO:0000269|PubMed:26091039}.
FT   MOD_RES     229    229       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P07724}.
FT   MOD_RES     297    297       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P07724}.
FT   MOD_RES     443    443       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     444    444       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     446    446       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     460    460       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P07724}.
FT   MOD_RES     513    513       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     543    543       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P07724}.
FT   MOD_RES     558    558       N6-methyllysine; alternate.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     588    588       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P07724}.
FT   CARBOHYD     36     36       N-linked (Glc) (glycation) lysine.
FT                                {ECO:0000305}.
FT   CARBOHYD     75     75       N-linked (Glc) (glycation) lysine; in
FT                                vitro.
FT   CARBOHYD    161    161       N-linked (Glc) (glycation) lysine; in
FT                                vitro.
FT   CARBOHYD    186    186       N-linked (Glc) (glycation) lysine; in
FT                                vitro.
FT   CARBOHYD    223    223       N-linked (Glc) (glycation) lysine; in
FT                                vitro.
FT   CARBOHYD    249    249       N-linked (Glc) (glycation) lysine; in
FT                                vitro.
FT   CARBOHYD    257    257       N-linked (Glc) (glycation) lysine.
FT                                {ECO:0000305}.
FT   CARBOHYD    300    300       N-linked (Glc) (glycation) lysine; in
FT                                vitro.
FT   CARBOHYD    305    305       N-linked (Glc) (glycation) lysine.
FT   CARBOHYD    337    337       N-linked (Glc) (glycation) lysine; in
FT                                vitro.
FT   CARBOHYD    341    341       N-linked (Glc) (glycation) lysine.
FT                                {ECO:0000305}.
FT   CARBOHYD    342    342       N-linked (GlcNAc...) asparagine; in
FT                                variant Redhill.
FT                                /FTId=CAR_000226.
FT   CARBOHYD    347    347       N-linked (Glc) (glycation) lysine; in
FT                                vitro.
FT   CARBOHYD    375    375       N-linked (Glc) (glycation) lysine.
FT                                {ECO:0000305}.
FT   CARBOHYD    402    402       N-linked (Glc) (glycation) lysine; in
FT                                vitro.
FT   CARBOHYD    437    437       N-linked (Glc) (glycation) lysine; in
FT                                vitro.
FT   CARBOHYD    463    463       N-linked (Glc) (glycation) lysine.
FT   CARBOHYD    468    468       N-linked (Glc) (glycation) lysine; in
FT                                vitro.
FT   CARBOHYD    518    518       N-linked (GlcNAc...) asparagine; in
FT                                variant Casebrook.
FT                                /FTId=CAR_000069.
FT   CARBOHYD    549    549       N-linked (Glc) (glycation) lysine.
FT   CARBOHYD    558    558       N-linked (Glc) (glycation) lysine;
FT                                alternate. {ECO:0000305}.
FT   CARBOHYD    560    560       N-linked (Glc) (glycation) lysine; in
FT                                vitro.
FT   CARBOHYD    569    569       N-linked (Glc) (glycation) lysine; in
FT                                vitro.
FT   CARBOHYD    597    597       N-linked (Glc) (glycation) lysine; in
FT                                vitro.
FT   DISULFID     77     86       {ECO:0000255|PROSITE-ProRule:PRU00769,
FT                                ECO:0000269|Ref.28}.
FT   DISULFID     99    115       {ECO:0000255|PROSITE-ProRule:PRU00769,
FT                                ECO:0000269|Ref.28}.
FT   DISULFID    114    125       {ECO:0000255|PROSITE-ProRule:PRU00769,
FT                                ECO:0000269|Ref.28}.
FT   DISULFID    148    193       {ECO:0000255|PROSITE-ProRule:PRU00769,
FT                                ECO:0000269|Ref.28}.
FT   DISULFID    192    201       {ECO:0000255|PROSITE-ProRule:PRU00769,
FT                                ECO:0000269|Ref.28}.
FT   DISULFID    224    270       {ECO:0000255|PROSITE-ProRule:PRU00769,
FT                                ECO:0000269|Ref.28}.
FT   DISULFID    269    277       {ECO:0000255|PROSITE-ProRule:PRU00769,
FT                                ECO:0000269|Ref.28}.
FT   DISULFID    289    303       {ECO:0000255|PROSITE-ProRule:PRU00769,
FT                                ECO:0000269|Ref.28}.
FT   DISULFID    302    313       {ECO:0000255|PROSITE-ProRule:PRU00769,
FT                                ECO:0000269|Ref.28}.
FT   DISULFID    340    385       {ECO:0000255|PROSITE-ProRule:PRU00769,
FT                                ECO:0000269|Ref.28}.
FT   DISULFID    384    393       {ECO:0000255|PROSITE-ProRule:PRU00769,
FT                                ECO:0000269|Ref.28}.
FT   DISULFID    416    462       {ECO:0000255|PROSITE-ProRule:PRU00769,
FT                                ECO:0000269|Ref.28}.
FT   DISULFID    461    472       {ECO:0000255|PROSITE-ProRule:PRU00769,
FT                                ECO:0000269|Ref.28}.
FT   DISULFID    485    501       {ECO:0000255|PROSITE-ProRule:PRU00769,
FT                                ECO:0000269|Ref.28}.
FT   DISULFID    500    511       {ECO:0000255|PROSITE-ProRule:PRU00769,
FT                                ECO:0000269|Ref.28}.
FT   DISULFID    538    583       {ECO:0000255|PROSITE-ProRule:PRU00769,
FT                                ECO:0000269|Ref.28}.
FT   DISULFID    582    591       {ECO:0000255|PROSITE-ProRule:PRU00769,
FT                                ECO:0000269|Ref.28}.
FT   VAR_SEQ      43    234       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.9}.
FT                                /FTId=VSP_021275.
FT   VAR_SEQ     164    376       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_057389.
FT   VARIANT      23     23       R -> C (in Redhill/Malmo-I/Tradate;
FT                                associated with T-344 in Redhill;
FT                                dbSNP:rs80008208).
FT                                {ECO:0000269|PubMed:1518850}.
FT                                /FTId=VAR_000499.
FT   VARIANT      23     23       R -> H (in Fukuoka-2/Lille/Taipei/Varese/
FT                                Komagome-3; dbSNP:rs72552709).
FT                                {ECO:0000269|PubMed:1946412,
FT                                ECO:0000269|PubMed:2247440,
FT                                ECO:0000269|PubMed:2911589}.
FT                                /FTId=VAR_000500.
FT   VARIANT      24     24       R -> L (in Jaffna; dbSNP:rs74821926).
FT                                /FTId=VAR_000501.
FT   VARIANT      24     24       R -> P (in Takefu/Honolulu-1;
FT                                dbSNP:rs74821926).
FT                                {ECO:0000269|PubMed:2404284}.
FT                                /FTId=VAR_000502.
FT   VARIANT      24     24       R -> Q (in Christchurch/Honolulu-2;
FT                                dbSNP:rs74821926).
FT                                {ECO:0000269|PubMed:2404284,
FT                                ECO:0000269|PubMed:2762316,
FT                                ECO:0000269|PubMed:2911589}.
FT                                /FTId=VAR_000503.
FT   VARIANT      25     25       D -> V (in Bleinheim/Iowa city-2;
FT                                dbSNP:rs75353611).
FT                                {ECO:0000269|PubMed:1946412}.
FT                                /FTId=VAR_000504.
FT   VARIANT      27     27       H -> Q (in Nagasaki-3; dbSNP:rs76285851).
FT                                /FTId=VAR_000505.
FT   VARIANT      27     27       H -> Y (in Larino; dbSNP:rs141733599).
FT                                {ECO:0000269|PubMed:17974005,
FT                                ECO:0000269|PubMed:8022807}.
FT                                /FTId=VAR_000506.
FT   VARIANT      73     73       F -> Y. {ECO:0000269|PubMed:11680902}.
FT                                /FTId=VAR_010657.
FT   VARIANT      84     84       E -> K (in Torino; dbSNP:rs77050410).
FT                                {ECO:0000269|PubMed:2247440}.
FT                                /FTId=VAR_000507.
FT   VARIANT      87     87       D -> N (in Malmo-95/Dalakarlia;
FT                                dbSNP:rs78574148).
FT                                {ECO:0000269|PubMed:1518850}.
FT                                /FTId=VAR_000508.
FT   VARIANT      90     90       L -> P (in FDAH; dbSNP:rs77892378).
FT                                {ECO:0000269|PubMed:9589637}.
FT                                /FTId=VAR_013011.
FT   VARIANT     106    106       E -> K (in Vibo Valentia;
FT                                dbSNP:rs80296402).
FT                                {ECO:0000269|PubMed:2247440}.
FT                                /FTId=VAR_000509.
FT   VARIANT     121    121       E -> G. {ECO:0000269|PubMed:6275391}.
FT                                /FTId=VAR_014290.
FT   VARIANT     138    138       R -> G (in Yanomama-2; dbSNP:rs77238412).
FT                                /FTId=VAR_000510.
FT   VARIANT     143    143       E -> K (in Nagoya; dbSNP:rs75522063).
FT                                {ECO:0000269|PubMed:2404284}.
FT                                /FTId=VAR_000511.
FT   VARIANT     146    146       V -> E (in Tregasio; dbSNP:rs77752336).
FT                                /FTId=VAR_013012.
FT   VARIANT     152    152       H -> R (in Komagome-2; dbSNP:rs80095457).
FT                                {ECO:0000269|PubMed:1946412}.
FT                                /FTId=VAR_000512.
FT   VARIANT     201    201       C -> F (in Hawkes bay; dbSNP:rs77656691).
FT                                {ECO:0000269|PubMed:8347685}.
FT                                /FTId=VAR_000513.
FT   VARIANT     215    215       A -> T (in dbSNP:rs3210154).
FT                                /FTId=VAR_014291.
FT   VARIANT     215    215       A -> V (in dbSNP:rs3204504).
FT                                /FTId=VAR_014292.
FT   VARIANT     220    220       Q -> L (in dbSNP:rs3210163).
FT                                /FTId=VAR_014293.
FT   VARIANT     242    242       R -> H (in FDAH; dbSNP:rs75002628).
FT                                {ECO:0000269|PubMed:7852505,
FT                                ECO:0000269|PubMed:8048949,
FT                                ECO:0000269|PubMed:9329347}.
FT                                /FTId=VAR_000514.
FT   VARIANT     242    242       R -> P (in FDAH; dbSNP:rs75002628).
FT                                /FTId=VAR_013013.
FT   VARIANT     249    249       K -> Q (in Tradate-2; dbSNP:rs79804069).
FT                                {ECO:0000269|PubMed:8022807}.
FT                                /FTId=VAR_000515.
FT   VARIANT     264    264       K -> E (in Herborn; dbSNP:rs79377490).
FT                                {ECO:0000269|PubMed:8513793}.
FT                                /FTId=VAR_000516.
FT   VARIANT     292    292       Q -> R (in Malmo-10; dbSNP:rs80002911).
FT                                {ECO:0000269|PubMed:1518850}.
FT                                /FTId=VAR_000517.
FT   VARIANT     293    293       D -> G (in Nagasaki-1; dbSNP:rs79744198).
FT                                {ECO:0000269|PubMed:2762316}.
FT                                /FTId=VAR_000518.
FT   VARIANT     300    300       K -> N (in Caserta; dbSNP:rs74718349).
FT                                {ECO:0000269|PubMed:8022807}.
FT                                /FTId=VAR_000519.
FT   VARIANT     337    337       K -> N (in Canterbury/New Guinea/
FT                                Tagliacozzo/Cuneo/Cooperstown;
FT                                dbSNP:rs72552710).
FT                                {ECO:0000269|PubMed:2404284,
FT                                ECO:0000269|PubMed:2911589,
FT                                ECO:0000269|PubMed:3828358}.
FT                                /FTId=VAR_000520.
FT   VARIANT     338    338       D -> G (in Bergamo; dbSNP:rs76242087).
FT                                /FTId=VAR_013014.
FT   VARIANT     338    338       D -> V (in Brest; dbSNP:rs76242087).
FT                                /FTId=VAR_013015.
FT   VARIANT     342    342       N -> K (in Malmo-47; dbSNP:rs77544362).
FT                                {ECO:0000269|PubMed:1518850}.
FT                                /FTId=VAR_000521.
FT   VARIANT     344    344       A -> T (in Redhill; associated with C-23;
FT                                dbSNP:rs78953271).
FT                                /FTId=VAR_000522.
FT   VARIANT     345    345       E -> K (in Roma; dbSNP:rs72552711).
FT                                /FTId=VAR_000523.
FT   VARIANT     357    357       E -> K (in Sondrio; dbSNP:rs77354753).
FT                                {ECO:0000269|PubMed:1347703}.
FT                                /FTId=VAR_000524.
FT   VARIANT     378    378       E -> K (in Hiroshima-1;
FT                                dbSNP:rs76593094).
FT                                {ECO:0000269|PubMed:2762316,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_000525.
FT   VARIANT     382    382       E -> K (in Coari I/Porto Alegre;
FT                                dbSNP:rs75791663).
FT                                /FTId=VAR_000526.
FT   VARIANT     383    383       K -> N (in Trieste; dbSNP:rs75069738).
FT                                /FTId=VAR_013016.
FT   VARIANT     389    389       D -> H (in Parklands; dbSNP:rs77187142).
FT                                /FTId=VAR_000527.
FT   VARIANT     389    389       D -> V (in Iowa city-1;
FT                                dbSNP:rs78538497).
FT                                {ECO:0000269|PubMed:1946412}.
FT                                /FTId=VAR_000528.
FT   VARIANT     396    396       K -> E (in Naskapi/Mersin/Komagome-1;
FT                                dbSNP:rs78166690).
FT                                {ECO:0000269|PubMed:1946412,
FT                                ECO:0000269|PubMed:3474609,
FT                                ECO:0000269|PubMed:3479777}.
FT                                /FTId=VAR_000529.
FT   VARIANT     399    399       D -> N (in Nagasaki-2; dbSNP:rs77514449).
FT                                {ECO:0000269|PubMed:3479777}.
FT                                /FTId=VAR_000530.
FT   VARIANT     400    400       E -> K (in Tochigi; dbSNP:rs79047363).
FT                                {ECO:0000269|PubMed:2762316}.
FT                                /FTId=VAR_000531.
FT   VARIANT     400    400       E -> Q (in Malmo-5; dbSNP:rs79047363).
FT                                {ECO:0000269|PubMed:1518850}.
FT                                /FTId=VAR_000532.
FT   VARIANT     406    406       E -> K (in Hiroshima-2;
FT                                dbSNP:rs76483862).
FT                                {ECO:0000269|PubMed:2762316}.
FT                                /FTId=VAR_000533.
FT   VARIANT     420    420       E -> K. {ECO:0000269|PubMed:6171778}.
FT                                /FTId=VAR_014294.
FT   VARIANT     434    434       R -> C (in Liprizzi; dbSNP:rs78575701).
FT                                /FTId=VAR_013017.
FT   VARIANT     490    490       K -> E (in dbSNP:rs1063469).
FT                                /FTId=VAR_014295.
FT   VARIANT     503    503       E -> K (in Dublin; dbSNP:rs80259813).
FT                                /FTId=VAR_000534.
FT   VARIANT     518    518       D -> N (in Casebrook; dbSNP:rs75920790).
FT                                {ECO:0000269|PubMed:1859851}.
FT                                /FTId=VAR_000535.
FT   VARIANT     525    525       E -> K (in Manaus-1/Adana/Lambadi/
FT                                Vancouver; dbSNP:rs75523493).
FT                                {ECO:0000269|PubMed:2404284}.
FT                                /FTId=VAR_000536.
FT   VARIANT     529    529       E -> K (in Ortonovo; dbSNP:rs74826639).
FT                                {ECO:0000269|PubMed:7902134}.
FT                                /FTId=VAR_000537.
FT   VARIANT     557    557       V -> M (in Maddaloni; dbSNP:rs78284052).
FT                                /FTId=VAR_013018.
FT   VARIANT     560    560       K -> E (in Castel di Sangro;
FT                                dbSNP:rs77645174).
FT                                /FTId=VAR_000538.
FT   VARIANT     565    565       K -> E (in Maku; dbSNP:rs80345158).
FT                                {ECO:0000269|PubMed:3479777}.
FT                                /FTId=VAR_000539.
FT   VARIANT     574    574       D -> A (in Malmo-61; dbSNP:rs79738788).
FT                                {ECO:0000269|PubMed:1518850}.
FT                                /FTId=VAR_000541.
FT   VARIANT     574    574       D -> G (in Mexico; dbSNP:rs79738788).
FT                                {ECO:0000269|PubMed:3474609}.
FT                                /FTId=VAR_000540.
FT   VARIANT     584    584       K -> E (in Church bay; dbSNP:rs76671808).
FT                                /FTId=VAR_013019.
FT   VARIANT     587    587       D -> N (in Fukuoka-1/Paris-2;
FT                                dbSNP:rs76587671).
FT                                {ECO:0000269|PubMed:1347703,
FT                                ECO:0000269|PubMed:2404284}.
FT                                /FTId=VAR_000542.
FT   VARIANT     589    589       E -> K (in Osaka-1; dbSNP:rs75709682).
FT                                {ECO:0000269|PubMed:2404284}.
FT                                /FTId=VAR_000543.
FT   VARIANT     594    594       E -> K (in Osaka-2/Phnom Phen/albumin B/
FT                                Verona; dbSNP:rs79228041).
FT                                {ECO:0000269|PubMed:2404284,
FT                                ECO:0000269|PubMed:2762316,
FT                                ECO:0000269|PubMed:2911589}.
FT                                /FTId=VAR_000544.
FT   VARIANT     596    609       GKKLVAASQAALGL -> PTMRIRERK (in Venezia).
FT                                /FTId=VAR_000547.
FT   VARIANT     597    597       K -> E (in Gent/Milano Fast;
FT                                dbSNP:rs80106970).
FT                                /FTId=VAR_000545.
FT   VARIANT     598    598       K -> N (in Vanves; dbSNP:rs75738598).
FT                                /FTId=VAR_000546.
FT   VARIANT     599    609       LVAASQAALGL -> TCCCKSSCLRLITSHLKASQPTMRIR
FT                                ERK (in Kenitra).
FT                                /FTId=VAR_012981.
FT   CONFLICT     55     55       L -> P (in Ref. 11; CAH18185).
FT                                {ECO:0000305}.
FT   CONFLICT    122    122       R -> S (in Ref. 4; AAF01333).
FT                                {ECO:0000305}.
FT   CONFLICT    155    155       E -> Q (in Ref. 19; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    174    174       Y -> L (in Ref. 24; AA sequence and 25;
FT                                AA sequence). {ECO:0000305}.
FT   CONFLICT    194    194       Q -> E (in Ref. 19; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    327    332       PSLAAD -> MFVLLC (in Ref. 10; AAF71067).
FT                                {ECO:0000305}.
FT   CONFLICT    405    405       V -> A (in Ref. 10; AAF71067).
FT                                {ECO:0000305}.
FT   CONFLICT    409    409       Q -> E (in Ref. 15; AAH14308).
FT                                {ECO:0000305}.
FT   CONFLICT    441    441       Q -> E (in Ref. 2; CAA23753).
FT                                {ECO:0000305}.
FT   CONFLICT    466    466       E -> G (in Ref. 4; AAF01333).
FT                                {ECO:0000305}.
FT   CONFLICT    488    489       HE -> EH (in Ref. 19; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    490    490       K -> R (in Ref. 11; CAH18185).
FT                                {ECO:0000305}.
FT   CONFLICT    525    525       E -> Q (in Ref. 19; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    551    551       T -> A (in Ref. 11; CAH18185).
FT                                {ECO:0000305}.
FT   CONFLICT    560    560       K -> R (in Ref. 11; CAH18185).
FT                                {ECO:0000305}.
FT   CONFLICT    604    604       Q -> R (in Ref. 5; AAN17825).
FT                                {ECO:0000305}.
FT   HELIX        30     38       {ECO:0000244|PDB:1N5U}.
FT   HELIX        40     54       {ECO:0000244|PDB:1N5U}.
FT   STRAND       55     58       {ECO:0000244|PDB:2BXH}.
FT   HELIX        60     79       {ECO:0000244|PDB:1N5U}.
FT   TURN         84     87       {ECO:0000244|PDB:1N5U}.
FT   HELIX        90     99       {ECO:0000244|PDB:1N5U}.
FT   TURN        101    103       {ECO:0000244|PDB:2BXH}.
FT   HELIX       104    108       {ECO:0000244|PDB:1N5U}.
FT   HELIX       109    116       {ECO:0000244|PDB:1N5U}.
FT   HELIX       119    128       {ECO:0000244|PDB:1N5U}.
FT   STRAND      130    132       {ECO:0000244|PDB:4N0F}.
FT   HELIX       144    153       {ECO:0000244|PDB:1N5U}.
FT   HELIX       155    169       {ECO:0000244|PDB:1N5U}.
FT   STRAND      171    173       {ECO:0000244|PDB:5ID7}.
FT   HELIX       175    192       {ECO:0000244|PDB:1N5U}.
FT   STRAND      195    197       {ECO:0000244|PDB:4L8U}.
FT   HELIX       198    230       {ECO:0000244|PDB:1N5U}.
FT   HELIX       232    246       {ECO:0000244|PDB:1N5U}.
FT   STRAND      248    250       {ECO:0000244|PDB:1BJ5}.
FT   HELIX       252    271       {ECO:0000244|PDB:1N5U}.
FT   HELIX       274    289       {ECO:0000244|PDB:1N5U}.
FT   HELIX       290    294       {ECO:0000244|PDB:1N5U}.
FT   HELIX       297    299       {ECO:0000244|PDB:4Z69}.
FT   HELIX       300    303       {ECO:0000244|PDB:1N5U}.
FT   HELIX       307    315       {ECO:0000244|PDB:1N5U}.
FT   HELIX       330    333       {ECO:0000244|PDB:1N5U}.
FT   STRAND      336    338       {ECO:0000244|PDB:2BXP}.
FT   HELIX       339    345       {ECO:0000244|PDB:1N5U}.
FT   HELIX       347    360       {ECO:0000244|PDB:1N5U}.
FT   STRAND      363    365       {ECO:0000244|PDB:4N0F}.
FT   HELIX       367    384       {ECO:0000244|PDB:1N5U}.
FT   STRAND      387    389       {ECO:0000244|PDB:1N5U}.
FT   HELIX       390    394       {ECO:0000244|PDB:1N5U}.
FT   HELIX       397    422       {ECO:0000244|PDB:1N5U}.
FT   HELIX       424    438       {ECO:0000244|PDB:1N5U}.
FT   STRAND      440    442       {ECO:0000244|PDB:2BXC}.
FT   HELIX       444    461       {ECO:0000244|PDB:1N5U}.
FT   STRAND      462    464       {ECO:0000244|PDB:2BXH}.
FT   HELIX       466    488       {ECO:0000244|PDB:1N5U}.
FT   STRAND      489    491       {ECO:0000244|PDB:4G03}.
FT   HELIX       495    502       {ECO:0000244|PDB:1N5U}.
FT   TURN        505    507       {ECO:0000244|PDB:1N5U}.
FT   HELIX       508    513       {ECO:0000244|PDB:1N5U}.
FT   STRAND      519    521       {ECO:0000244|PDB:4E99}.
FT   HELIX       529    531       {ECO:0000244|PDB:1N5U}.
FT   HELIX       535    538       {ECO:0000244|PDB:1N5U}.
FT   HELIX       542    559       {ECO:0000244|PDB:1N5U}.
FT   STRAND      561    563       {ECO:0000244|PDB:1E7A}.
FT   HELIX       565    583       {ECO:0000244|PDB:1N5U}.
FT   STRAND      584    587       {ECO:0000244|PDB:1N5U}.
FT   HELIX       588    590       {ECO:0000244|PDB:2BXG}.
FT   TURN        591    593       {ECO:0000244|PDB:1N5U}.
FT   HELIX       594    606       {ECO:0000244|PDB:1N5U}.
SQ   SEQUENCE   609 AA;  69367 MW;  F88FF61DD242E818 CRC64;
     MKWVTFISLL FLFSSAYSRG VFRRDAHKSE VAHRFKDLGE ENFKALVLIA FAQYLQQCPF
     EDHVKLVNEV TEFAKTCVAD ESAENCDKSL HTLFGDKLCT VATLRETYGE MADCCAKQEP
     ERNECFLQHK DDNPNLPRLV RPEVDVMCTA FHDNEETFLK KYLYEIARRH PYFYAPELLF
     FAKRYKAAFT ECCQAADKAA CLLPKLDELR DEGKASSAKQ RLKCASLQKF GERAFKAWAV
     ARLSQRFPKA EFAEVSKLVT DLTKVHTECC HGDLLECADD RADLAKYICE NQDSISSKLK
     ECCEKPLLEK SHCIAEVEND EMPADLPSLA ADFVESKDVC KNYAEAKDVF LGMFLYEYAR
     RHPDYSVVLL LRLAKTYETT LEKCCAAADP HECYAKVFDE FKPLVEEPQN LIKQNCELFE
     QLGEYKFQNA LLVRYTKKVP QVSTPTLVEV SRNLGKVGSK CCKHPEAKRM PCAEDYLSVV
     LNQLCVLHEK TPVSDRVTKC CTESLVNRRP CFSALEVDET YVPKEFNAET FTFHADICTL
     SEKERQIKKQ TALVELVKHK PKATKEQLKA VMDDFAAFVE KCCKADDKET CFAEEGKKLV
     AASQAALGL
//
